These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8486192)

  • 1. Placebo effect--how powerful?
    Schmidt PJ; Rubinow DR
    Fertil Steril; 1993 May; 59(5):1144-5. PubMed ID: 8486192
    [No Abstract]   [Full Text] [Related]  

  • 2. Successful management of predicted severe ovarian hyperstimulation syndrome with gonadotropin-releasing hormone agonist.
    Wu TC; Gelety TJ; Jih MH; Fournet N; Buyalos R
    J Assist Reprod Genet; 1992 Jun; 9(3):281-3. PubMed ID: 1525462
    [No Abstract]   [Full Text] [Related]  

  • 3. Gonadotropin-releasing hormone agonist (leuprolide acetate) induced ovarian hyperstimulation syndrome in a woman undergoing intermittent hemodialysis.
    Hampton HL; Whitworth NS; Cowan BD
    Fertil Steril; 1991 Feb; 55(2):429-31. PubMed ID: 1899400
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome.
    Schmidt PJ; Nieman LK; Danaceau MA; Adams LF; Rubinow DR
    N Engl J Med; 1998 Jan; 338(4):209-16. PubMed ID: 9435325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gonadotropin-releasing hormone agonist in the treatment of premenstrual symptoms with and without ongoing dysphoria: a controlled study.
    Freeman EW; Sondheimer SJ; Rickels K
    Psychopharmacol Bull; 1997; 33(2):303-9. PubMed ID: 9230648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term management of adenomyosis with a gonadotropin-releasing hormone agonist: a case report.
    Nelson JR; Corson SL
    Fertil Steril; 1993 Feb; 59(2):441-3. PubMed ID: 8425643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Double-stimulation tests with an analogue of LH-RH in polycystic ovarian syndrome].
    Zhou JP
    Zhonghua Fu Chan Ke Za Zhi; 1985 Nov; 20(6):344-8, 383. PubMed ID: 3938729
    [No Abstract]   [Full Text] [Related]  

  • 8. Combined oestrogen-progestin treatment of vaginal haemorrhage following gonadotrophin-releasing hormone agonist therapy of uterine myomas.
    Friedman AJ
    Hum Reprod; 1993 Apr; 8(4):540-2. PubMed ID: 8501181
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An evaluation of the effect of gonadotropin-releasing hormone analogs and medroxyprogesterone acetate on uterine leiomyomata volume by magnetic resonance imaging: a prospective, randomized, double blind, placebo-controlled, crossover trial.
    Carr BR; Marshburn PB; Weatherall PT; Bradshaw KD; Breslau NA; Byrd W; Roark M; Steinkampf MP
    J Clin Endocrinol Metab; 1993 May; 76(5):1217-23. PubMed ID: 8496313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anti-tumor effects of GnRH analogs in gynecological cancers].
    Yano T; Taketani Y
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():127-31. PubMed ID: 16689297
    [No Abstract]   [Full Text] [Related]  

  • 11. Deslorelin. D-Trp-LHRH-PEA, LHRH agonist analogue, Somagard.
    Drugs R D; 1999 Dec; 2(6):420-2. PubMed ID: 10763456
    [No Abstract]   [Full Text] [Related]  

  • 12. Premenstrual syndrome.
    Vaitukaitis JL
    N Engl J Med; 1984 Nov; 311(21):1371-3. PubMed ID: 6387490
    [No Abstract]   [Full Text] [Related]  

  • 13. Leuprolide acetate elevates prolactin during ovarian stimulation with gonadotropins.
    Meldrum DR; Cedars MI; Hamilton F; Huynh D; Wisot A; Marr B
    J Assist Reprod Genet; 1992 Jun; 9(3):251-3. PubMed ID: 1525456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gonadotropin-releasing hormone agonist-induced ovarian hyperstimulation: low-dose side effects in women and monkeys.
    Navot D; Rosenwaks Z; Anderson F; Hodgen GD
    Fertil Steril; 1991 Jun; 55(6):1069-75. PubMed ID: 1828042
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Confounders?
    Taskin O; Kursun S; Simsek M; Trak B
    Fertil Steril; 2001 Oct; 76(4):850-2. PubMed ID: 11680434
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of different add-back estradiol and progesterone treatments to gonadotropin-releasing hormone agonist treatment in patients with premenstrual dysphoric disorder.
    Segebladh B; Borgström A; Nyberg S; Bixo M; Sundström-Poromaa I
    Am J Obstet Gynecol; 2009 Aug; 201(2):139.e1-8. PubMed ID: 19398092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Premenstrual syndrome and related hormonal changes. Long-acting gonadotropin releasing hormone agonist treatment.
    Helvacioglu A; Yeoman RR; Hazelton JM; Aksel S
    J Reprod Med; 1993 Nov; 38(11):864-70. PubMed ID: 8277482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gonadotropin-releasing hormone agonists induce meiotic maturation and degeneration of oocytes in the in vitro perfused rabbit ovary.
    Yoshimura Y; Nakamura Y; Yamada H; Nanno T; Ubukata Y; Ando M; Suzuki M
    Fertil Steril; 1991 Jan; 55(1):177-83. PubMed ID: 1898889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of the action of sex steroids by gonadotropin-releasing hormone (GnRH) agonists: a new biological effect.
    Sundaram K; Cao YQ; Wang NG; Bardin CW; Rivier J; Vale W
    Life Sci; 1981 Jan; 28(1):83-8. PubMed ID: 7012514
    [No Abstract]   [Full Text] [Related]  

  • 20. A conservative approach to the management of uterine leiomyoma: pituitary desensitization by a luteinizing hormone-releasing hormone analogue.
    Filicori M; Hall DA; Loughlin JS; Rivier J; Vale W; Crowley WF
    Am J Obstet Gynecol; 1983 Nov; 147(6):726-7. PubMed ID: 6356927
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.